Market Overview

Benzinga's Top Downgrades

Share:
Related FINL
Mid-Afternoon Market Update: Crude Oil Down 4%; Imperva Shares Spike Higher
12 Biggest Mid-Day Losers For Friday
The Finish Line's (FINL) CEO Sam Sato on Q2 2017 Results - Earnings Call Transcript (Seeking Alpha)
Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.

Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.

RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.

William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.

Latest Ratings for FINL

DateFirmActionFromTo
Sep 2016B. RileyMaintainsBuy
Sep 2016Deutsche BankDowngradesBuyHold
Jul 2016Deutsche BankMaintainsBuy

View More Analyst Ratings for FINL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AMLN + BAH)

View Comments and Join the Discussion!